Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.3

-0.27

-0.25

-0.22

Details

Expected EPS

-0.25078352672

Actual EPS

-0.2245802

Surprise EPS

0.03

Surprise Percent

+10.45%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.2245802 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.